Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement | Patent Publication Number 20170349652

US 20170349652 A1
Patent NumberUS 10590189 B2
Application Number15642096
Filled DateJul 5, 2017
Priority DateMar 15, 2007
Publication DateDec 7, 2017
Original AssigneeAstrazeneca
Current AssigneeAlexion Pharmaceuticals
Inventor/ApplicantsRussell P. ROTHER
Mark J. EVANS
Russell P. Rother
Leonard Bell
Mark J. Evans
Leonard BELL
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.